Dallas, TX, United States of America

Melaine Cobb

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2006.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melaine Cobb: Innovator in Protein Kinase Research

Introduction

Melaine Cobb is a notable inventor based in Dallas, TX (US). She has made significant contributions to the field of biochemistry, particularly in the area of protein kinases. Her work focuses on the development of therapeutic methods that target specific signaling pathways involved in various diseases.

Latest Patents

Melaine Cobb holds a patent for "TAO protein kinase polypeptides and methods of use therefor." This patent describes compositions and methods for potentiating the activity of the mitogen-activated protein kinase p38. Specifically, it involves the mitogen-activated protein kinase kinase MEK6 and variants that stimulate the phosphorylation of p38. These compounds have potential applications in the therapy of diseases associated with the p38 cascade and in identifying antibodies and other agents that can inhibit or activate signal transduction via p38. She has 1 patent to her name.

Career Highlights

Melaine Cobb is affiliated with the University of Texas System, where she conducts her research. Her work has been instrumental in advancing our understanding of protein kinases and their role in cellular signaling.

Collaborations

Melaine collaborates with several esteemed colleagues, including Michelle Hutchinson and Zhu Chen. Their combined expertise enhances the research output and innovation in their field.

Conclusion

Melaine Cobb's contributions to protein kinase research exemplify the impact of innovative thinking in the scientific community. Her patent and ongoing work continue to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…